Tech Company Financing Transactions
Altor Bioscience Funding Round
Sanderling Ventures joined a $1.4 million funding round for Altor Bioscience. The funding round closed on 9/30/2010.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$1,375,000
Round
Undisclosed
Investors
Sanderling Ventures (Fred Middleton)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2810 North Commerce Pkwy.
Miramar, FL 33025
USA
Miramar, FL 33025
USA
Phone
Website
Email Address
Overview
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hing Wong
VP - R & D
Peter Rhode
Browse more venture capital transactions:
Prev: 9/30/2010: BioVex venture capital transaction
Next: 9/30/2010: Acton Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs